Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Diseases × nimotuzumab × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 18 Squamous Cell Carcinoma of Head and Neck 8 Head and Neck Neoplasms 6 Recurrence 2 Nasopharyngeal Neoplasms 2 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Diseases 1 Hypopharyngeal Neoplasms 1 Carcinoma 1

Interventions

Cisplatin 2 pembrolizumab 1 nimotuzumab 1 Re-Irradiation 1 Gemcitabine 1 Fluorouracil 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03837808 2022-11-07

Radiotherapy Plus Concurrent Nimotuzumab or Cisplatin in Stage II-III Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Unknown

Nasopharyngeal Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Diseases, Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡